Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Helsinn Therapeutics (U.S.), Inc
Scientific Title
A Phase III, Double-Blind, Placebo-Controlled, Multicenter, Randomized Study Of Pracinostat In Combination With Azacitidine In Patients ≥18 Years With Newly Diagnosed Acute Myeloid Leukemia Unfit For Standard Induction Chemotherapy